VTE Trial: As DOACs Face Off, Apixaban Confirmed Safer – Medscape March 12, 2026 by live-feeds VTE Trial: As DOACs Face Off, Apixaban Confirmed Safer Medscape Apixaban safer than rivaroxaban for treating venous thrombosis News-Medical Source link Share this: Share on Facebook (Opens in new window) Facebook Share on X (Opens in new window) X Related Related posts: India well-prepared to handle respiratory illnesses, says Health Ministry on HMPV outbreak in China – The Hindu 5 ways to reduce your dementia risk as study estimates U.S. cases could double by 2060 Flood Stress Causes Fear Anxiety and Insomnia in Citizens Is Primary Opening of Fistula-in-ano Always at Dentate Line: Correlati